Status:
UNKNOWN
Early Diagnosis of GDM by Multiomics
Lead Sponsor:
Women's Hospital School Of Medicine Zhejiang University
Conditions:
Gestational Diabetes Mellitus
Eligibility:
FEMALE
20-49 years
Brief Summary
Gestational diabetes mellitus (GDM) is prone to cause a variety of adverse pregnancy outcomes, and has potential harm to the short-term and long-term health of both mothers and infants. However, its d...
Eligibility Criteria
Inclusion
- Plan to have routine prenatal examinations and give birth in the research center
- First trimester
- Singleton pregnancy
- Without pregnancy complications
- Willing to cooperate with the hospital to follow up
Exclusion
- Have diseases that affect metabolic function or even threaten the life of the mother and fetus before pregnancy, such as diabetes, heart disease, liver and kidney diseases, thyroid diseases with drug, autoimmune diseases, malignant tumors, AIDS, etc.
- Fetus has a known deformity or genetic defects
- Incomplete clinical data
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT05386927
Start Date
May 1 2022
End Date
December 31 2024
Last Update
October 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women's Hospital School Of Medicine Zhejiang University
Hangzhou, Zhejiang, China, 310006